(Portugal), 2026 Nuovi farmaci per il diabete e l'obesit: AIFA guide to responsible use, Wegovy class C classification Agenzia Italiana del Farmaco (AIFA), 2026 Mounjaro (tirzepatide): European Public Assessment Report overview European Medicines Agency, 2026 Saxenda (liraglutide): European Public Assessment Report overview European Medicines Agency, 2026 Saxenda 6 mg/mL solution for injection: Summary of Product Characteristics electronic medicines compendium (emc), 2026 Xenical (orlistat): European Public Assessment Report overview European Medicines Agency, 2026 Reviewed by Hi-Doctor's medical team Last reviewed 2026-07-27 Next review due 2027-07-27 This page is educational information about a medicine, not a recommendation to take it and not a substitute for a medical consultation
Pregnant or Breastfeeding Women: The increased nutritional needs during pregnancy and breastfeeding may require B12 supplementation to support both mother and child
J Nutr 2018
Despite some data showing differing bioavailability by injection site, the FDA highlights that the maximal subcutaneous bioavailability of semaglutide is 89%
When considering MIC B12 injections, it's important to weigh the costs, potential benefits, and individual health factors
